GENELUX CORPORATION Investment Income, Interest
GENELUX CORPORATION (GNLX) reported Investment Income, Interest of $127.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-13
- GENELUX CORPORATION investment income, interest for the quarter ending 2026-06-30 was $127.00K, a 43.30% decline year-over-year.
- GENELUX CORPORATION investment income, interest for the quarter ending 2026-03-31 was $173.00K, a 5.98% decline year-over-year.
- GENELUX CORPORATION investment income, interest for the quarter ending 2025-12-31 was $128.00K, a 36.32% decline year-over-year.
- GENELUX CORPORATION investment income, interest for the quarter ending 2025-09-30 was $175.00K, a 21.17% decline year-over-year.
- GENELUX CORPORATION investment income, interest for fiscal 2025 was $711.00K, a 1.57% increase from fiscal 2024.
- GENELUX CORPORATION investment income, interest for fiscal 2024 was $700.00K, a 284.62% increase from fiscal 2023.
- GENELUX CORPORATION investment income, interest for fiscal 2023 was $182.00K.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 3 month as first filed | Investment Income, Interest 6 month | Investment Income, Interest 6 month as first filed | Investment Income, Interest 9 month | Investment Income, Interest 9 month as first filed | Investment Income, Interest 12 month | Investment Income, Interest 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $127.00K 10-Q · filed 2026-08-13 | $300.00K 10-Q · filed 2026-08-13 | $428.00K derived: sum of 3 quarters · filed 2026-08-13 | $603.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $173.00K 10-Q · filed 2026-05-07 | $301.00K derived: sum of 2 quarters · filed 2026-05-07 | $476.00K derived: sum of 3 quarters · filed 2026-05-07 | $700.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $128.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $303.00K derived: sum of 2 quarters · filed 2026-03-19 | $527.00K derived: sum of 3 quarters · filed 2026-08-13 | $711.00K 10-K · filed 2026-03-19 | ||||
| 2025-09-30 | $175.00K 10-Q · filed 2025-11-05 | $399.00K derived: sum of 2 quarters · filed 2026-08-13 | $583.00K 10-Q · filed 2025-11-05 | $784.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $224.00K 10-Q · filed 2026-08-13 | $408.00K 10-Q · filed 2026-08-13 | $609.00K derived: sum of 3 quarters · filed 2026-08-13 | $831.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $184.00K 10-Q · filed 2026-05-07 | $385.00K derived: sum of 2 quarters · filed 2026-05-07 | $607.00K derived: sum of 3 quarters · filed 2026-05-07 | $770.00K derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $201.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $423.00K derived: sum of 2 quarters · filed 2026-03-19 | $586.00K derived: sum of 3 quarters · filed 2026-03-19 | $700.00K 10-K · filed 2026-03-19 | ||||
| 2024-09-30 | $222.00K 10-Q · filed 2025-11-05 | $474.00K 10-Q · filed 2024-11-14 | $385.00K derived: sum of 2 quarters · filed 2025-11-05 | $499.00K 10-Q · filed 2025-11-05 | $1.05M 10-Q · filed 2024-11-14 | $677.00K derived: sum of 4 quarters · filed 2025-11-05 | ||
| 2024-06-30 | $163.00K 10-Q · filed 2025-08-07 | $316.00K 10-Q · filed 2024-08-14 | $277.00K 10-Q · filed 2025-08-07 | $581.00K 10-Q · filed 2024-08-14 | $455.00K derived: sum of 3 quarters · filed 2025-08-07 | $459.00K derived: sum of 4 quarters · filed 2025-08-07 | ||
| 2024-03-31 | $114.00K 10-Q · filed 2025-05-06 | $265.00K 10-Q · filed 2024-05-09 | $292.00K derived: sum of 2 quarters · filed 2025-05-06 | $296.00K derived: sum of 3 quarters · filed 2025-05-06 | ||||
| 2023-12-31 | $178.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $182.00K derived: sum of 2 quarters · filed 2025-03-28 | $182.00K 10-K · filed 2025-03-28 | $244.00K 10-K · filed 2024-03-29 | ||||
| 2023-09-30 | $4.00K 10-Q · filed 2024-11-14 | $4.00K 10-Q · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |